Company Profile
What's New
Product Information
Applications Info
Tech Reference List
Information Request
Contact Us
Careers
Email Newsletter
Frequently Asked Questions
In Vitro Basics
In Vitro Toxicology Testing (Non-Animal Safety Testing)
Nanoparticle Research Using MatTek Human Tissue Constructs
Site Map
Search




MatTek Corporation
200 Homer Avenue
Ashland, MA  01721
508-881-6771
FAX:  508-879-1532
E-mail Us

Data Sheet Specification Sheet Technical References
Front page
Search

The EpiOcular Model

EpiOcular-Specific Features:

General MatTek Tissue Features:

  • Unsurpassed Long-Term Tissue Reproducibility -
    Lot-to-Lot, Year-to-Year
  • 3-Dimensional, Highly Differentiated Tissues
  • Metabolically, Mitotically Active Tissues
  • Produced from Normal (Non-Transformed) Human Cells - Ideal for Genomics Studies
  • Produced in Easily Handled Cell Culture Inserts
  • Grown in Completely Serum-Free Media System
  • Quantifiable, Objective Test Endpoints
  • Cost Effective Alternative to Animal and Human Clinical Testing
  • List of Contract Testing Labs Qualified to Run MatTek Tissue-Based Tests Available

NOTE: Link to EpiOcular Technical Specifications

MatTek's EpiOcular™ corneal model consists of normal, human-derived epidermal keratinocytes which have been cultured to form a stratified, squamous epithelium similar to that found in the cornea. The epidermal cells, which are cultured on specially prepared cell culture inserts using serum free medium, differentiate to form a multi-layered structure which closely parallels the corneal epithelium.

The EpiOcular tissue model exhibits in vivo-like morphological and growth characteristics which are uniform and highly reproducible. EpiOcular consists of highly organized basal cells which progressively flatten out as the apical surface of the tissue is approached, analogous to the normal in vivo corneal epithelium. EpiOcular is mitotically and metabolically active and releases many of the pro-inflammatory agents (cytokines) known to be important in ocular irritation and inflammation.

The protocols for using the EpiOcular System are clear and straightforward. EpiOcular has been utilized with several common tests of cytotoxicity and irritancy, including MTT, IL-1α, PGE2, LDH, and sodium fluorescein permeability. Technicians find EpiOcular's rigid substrate design easy to handle in routine repetitive testing environments and scientists find that they are able to perform discriminating tests due to the model's high level of reproducibility. In fact, "Sub-Draize" testing is possible with EpiOcular, allowing quantifiable discrimination among mild, milder, and mildest product formulations.

Various industrial and toxicology laboratories are actively seeking alternatives to whole animal testing. Cosmetic, household product, pharmaceutical and petrochemical companies have initiated in vitro toxicology testing to evaluate their raw materials and final product formulations. A growing body of data indicates that EpiOcular effectively provides a non-animal means to assess ocular irritation and other toxicological issues.

For all of these reasons, the EpiOcular model provides a predictive, morphologically relevant in vitro means to assess ocular irritancy.

HISTOLOGY:
EpiOcular vs. Rabbit Cornea
Formalin Fixed, Paraffin Embedded, H&E Stained

EpiOcular: Magnification 360x
Rabbit Cornea: Magnification 360x

OCL-200 Prediction Equation

ET-50 (min)

Figure 1:  Determination of EpiOcular prediction model -- Correlation of MTT ET-50 results to Draize rabbit eye data.

 

 

ECETOC Materials (Figure 1)*

ET-50
avg (min)

Actual
Draize
(MMAS)

1

Benzalkonium Chloride (1%)

5.9

45.3

2

Benzalkonium Chloride (5%)

1.0

83.8

3

Benzalkonium Chloride (10%)

1.1

108.0

4

Cetyl Pyridinium Bromide (0.1%)

>240

2.7

5

Cetyl Pyridinium Bromide (1%)

30.1

36.0

6

Cetyl Pyridinium Bromide (10%)

9.0

89.7

7

Glycerol

>240

1.7

8

Propylene Glycol

>240

1.3

9

Sodium Dodecyl Sulfate (3%)

9.0

16.0

10

Sodium Dodecyl Sulfate (15%)

5.1

59.2

11

Sodium Dodecyl Sulfate (30%)

2.1

60.5

12

Sodium Hydroxide (1%)

2.3

25.8

13

Sodium Hydroxide (10%)

1.0

108.0

14

Tri-chloro acetic acid (3%)

155.1

6.7

15

Tri-chloro acetic acid (30%)

1.0

106.0

16

Triton X-100 (1%)

36.7

1.7

17

Triton X-100 (5%)

5.3

33.1

18

Triton X-100 (10%)

2.5

68.7

19

Tween 20 (100%)

>240

4.0

 

 

 

 

 

Surfactants (Figure 1)*

 

 

20

Cetrimonium chloride

116.9

6.7

21

Cocamide DEA

>240

0.0

22

Disodium cocoamphodipropionate

11.2

15.3

23

Na2-ricinoleadmido MEA sulfosuccinate

108.9

0.0

24

Sodium cocoamphopropionate

7.1

45.0

25

Sodium trideceth sulfate

2.5

33.0

26

Stearalkonium chloride

>240

14.0

27

Surfactant blend

19.2

6.0

28

Surfactant blend

40.4

2.7

 

 

 

 

 

Consumer Products (Figure 1)*

 

 

29

10% fatty alcohol ethoxylate

189.0 

3.5

30

Body spray

>240 

0.0

31

Body/hand Wash

9.1 

32.0

32

Body/hand Wash

14.8 

35.0

33

Eye Gel/Colorant

>240 

0.0

34

Eye Gel/Colorant

>240

2.0

35

Eye makeup remover (surfactant solution)

>240 

0.0

36

Face/body Wash

>240 

2.0

37

Face/body Wash

6.5 

25.0

38

Face/body Wash

10.2 

40.0

39

Final formulation shampoo

63.1 

3.5

40

Final formulation shampoo

31.0 

3.9

41

Final formulation shampoo

26.1 

4.0

42

Final formulation shampoo

42.1 

4.8

43

Final formulation shampoo

29.4 

6.6

44

Final formulation shampoo

47.1 

8.3

45

Final formulation shampoo

29.1 

12.5

46

Final formulation shampoo

9.3 

31.6

47

Final formulation shampoo

4.2 

32.7

48

Final formulation shampoo

9.0 

34.4

49

Hair conditioner

>240 

2.0

50

Hand/body Lotion

>240 

2.0

51

Hand/body Lotion

>240 

2.0

52

Hand/body Lotion

>240

3.0

53

Hydroalcohol (air spray) solution

84.1 

6.0

54

Lactic acid (3%)

>240 

0.0

55

Oleic acid

>240 

2.0

56

Shampoo - baby

30.8

10.0

57

Shampoo - baby

25.7 

18.0

58

Shampoo - regular

6.0 

30.0

59

Shampoo - regular

8.7 

35.0

60

Skin care emulsion

>240 

0.0

 

Testing of OCL-200 Prediction Model
In Vivo (MMAS) vs. Predicted Draize

In Vivo Draize (MMAS)

Figure 2:  Comparison of actual Draize to predicted Draize score based on correlation equation (Figure 1).

 

 

Consumer Products (Figure 2)*

Predicted
Draize

Actual
Draize
(MMAS)

 

 

 

 

1

Body wash

14.6

16.7

2

Body wash

31.3

44.7

3

Dishwashing liquid

51.3

38.3

4

Hand soap liquid

28.0

24.7

5

Dishwashing liquid

25.2

39.3

6

Facial soap

15.6

9.3

7

Dishwashing liquid

50.8

39.0

8

Dishwashing liquid

60.5

50.3

9

Laundry detergent

37.3

37.3

10

Laundry detergent

1.8

0.7

11

Laundry detergent

33.4

37.7

12

Dishwashing liquid

96.9

37.7

13

Shampoo

6.5

4.0

14

Shampoo

32.9

41.7

15

Shampoo

8.4

3.3

16

Hand soap liquid

18.1

13.3

17

Skin lotion

1.8

0.7

18

Shampoo

46.9

33.7

19

Skin lotion

1.8

0.0

20

Shampoo

39.3

37.7

21

Body wash

41.2

33.0

22

Laundry detergent

1.8

0.7

23

Laundry detergent

39.9

44.0

24

Skin lotion

1.8

0.7

*  All materials diluted to 20% in ultrapure water prior to testing
(density > 0.95 g/ml).

====================

Request A Price List or a Quotation
(Note: There are no In Vitro Product prices on this Web site.)

Please Also Review:

Guide to In Vitro Tissue Model Basics

EpiOcular Specification Sheet

EpiOcular Technical References


Psoriasis Tissue
Dendritic (Langerhans) Cells
EpiAirway Normal Human Airway Tissue Model
EpiDerm Reconstructed Human Epidermis (RhE) Tissue Model
EpiDerm-201 Under-developed Skin Model
EpiDermFT™ Skin Model
EpiOcular Normal Human Corneal Tissue Model
EpiOral Normal Human Buccal, EpiGingival Normal Human Gum Tissue Models
EpiVaginal Normal Human Ecto-Cervical Vaginal Tissue Model
MelanoDerm Normal Human Skin Model with Melanocytes
Melanoma Skin Model
Top